Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

Biotechnology

Healthcare
$2.29 +0.67%

+$0.02 today

Market cap
$165.63M
Beta
0.35
P/E (TTM)
-1.3
EPS (TTM)
-$1.79
52W Low $1.10High $3.60

Volume 0.81M

Average 0.40M

Balance Sheet

Inspect the capital base behind the business.

Assets

$122.83M

FY 2025 · Annual

-48.6% YoY

Liabilities

$52.40M

FY 2025 · Annual

-8.3% YoY

Equity

$70.43M

FY 2025 · Annual

-61.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents122.16M130.1M66.89M35.63M53.99M
Short-term Investments72.08M47.5M176.64M135.93M62.88M
Net Receivables00225K0625K
Inventory0199K0159K0
Other Current Assets2.83M1.42M1.96M5.73M4.16M
Total Current Assets198.66M180.33M246.62M178.31M122.25M
Property, Plant & Equipment (Net)36K270K503K339K243K
Goodwill00000
Intangible Assets00169K029K
Long-term Investments31.62M15.84M62.55M59.97M0
Tax Assets0000163K
Other Non-current Assets14K151K285K379K146K
Total Non-current Assets31.67M16.26M63.51M60.69M581K
Total Assets230.33M196.59M310.13M238.99M122.83M
Account Payables1.09M1.64M1.38M5.65M554K
Short-term Debt00008.92M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.96M131K3.9M230K4.25M
Total Current Liabilities5.15M7.81M12.97M27.61M30.01M
Long-term Debt0027.34M29.42M22.4M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities002.56M00
Total Non-current Liabilities0030.18M29.57M22.4M
Total Liabilities5.15M7.81M43.15M57.18M52.4M
Common Stock4K4K6K6K6K
Retained Earnings(127.57M)(170.43M)(222.8M)(325.13M)(446.46M)
Accumulated OCI(231K)(751K)312K(48K)83K
Other Stockholders Equity00000
Minority Interest00000
Total Equity225.18M188.78M266.97M181.82M70.43M
Total Debt0105K28.49M29.7M31.31M
Net Debt(122.16M)(130M)(38.4M)(5.93M)(22.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$51.8M
Short-term Investments$76.6M
Receivables$772.0K
Other Current$3.9M
Total Current Assets$133.1M
PP&E (Net)$197.0K
Intangible Assets$24.0K
Long-term Investments$231.0K
Other Non-current$83.0K
Total Non-current Assets$535.0K
Total Assets$133.6M

Analysis

Selected assets total $133.6M for Latest. The largest visible component is Short-term Investments at $76.6M, about 57.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 16, 2026
S-8S-8 filingAug 12, 2026
8-KCurrent reportAug 12, 2026
10-QQuarterly reportAug 12, 2026
4Statement of changes in beneficial ownershipJun 17, 2026

How much cash does ABOS have?

Acumen Pharmaceuticals, Inc. (ABOS) reported $53.99M in cash and equivalents in fiscal 2025.

How much debt does ABOS carry?

Acumen Pharmaceuticals, Inc. (ABOS) reported $31.31M of total debt, with net debt of -$22.68M.